Kisspeptin Peptide Screening Form Template

Kisspeptin is a naturally occurring neuropeptide that plays a central role in regulating the hypothalamic-pituitary-gonadal (HPG) axis. It stimulates GnRH release, driving LH and FSH secretion to support reproductive hormone function. It is prescribed off-label through compounding pharmacies for patients with reduced libido, fertility concerns, and symptoms of hormonal dysregulation. This screening form helps providers document reproductive health symptoms and evaluate contraindications before initiating kisspeptin therapy.

4 sections
17 fields
HIPAA-ready
3 citations

Free Template

Kisspeptin Peptide Screening Form

Preview Form Automate This Form
No account required to use template
Customize with your practice branding
Reviewed against HIPAA & DEA guidelines

Form Preview

This is how the form appears to patients. Customize with your practice name and branding.

Your Practice Name

Kisspeptin Peptide Screening Form

Preview
1

General Patient Information

Please provide your personal information.

First Name

Jane

Last Name

Smith

Date of Birth

Can you confirm you are 18 years or older?

Height

e.g. 5'8"

Weight

e.g. 170 lbs

2

Medical History

Please answer all questions as accurately as possible. Your provider will review this information.

Are you actively taking any medications? If so, please list them.

List all current medications, dosages, and frequencies

Do you have any medication allergies? If so, please list them.

List all known drug allergies and reactions

Are you currently being treated or have you been treated for any medical conditions? If so, please list them.

List all current and past medical conditions

Have you had any past surgeries? If so, please list them.

List all surgeries and approximate dates

What is/was your sex assigned at birth?

Male

Emergency contact name and phone number

Name — (555) 000-0000

Mailing address

123 Main St, City, State, ZIP

Any other questions or concerns?

Optional — share anything else you'd like your provider to know

3

Symptoms

Select all symptoms that currently apply to you.

Which of the following symptoms are you experiencing?
4

Medical Conditions

Select all conditions that currently apply to you.

Do any of the following apply to you?

Preview only. Your live form will include your branding and e-signature capture.

Submit

Compliance & Regulatory Notes

Review these notes before deploying this form in your practice.

Kisspeptin is not FDA-approved for clinical use and must be prescribed off-label with documented informed consent. See FSMB: https://www.fsmb.org

Kisspeptin use during pregnancy or active fertility monitoring requires specialist coordination. Providers should consult reproductive endocrinology guidance when treating fertility patients.

Hormone-sensitive cancers (e.g., estrogen-receptor positive breast cancer, prostate cancer) are contraindications. Obtain oncology clearance if applicable.

Kisspeptin must be dispensed by a licensed compounding pharmacy. See FDA: https://www.fda.gov/drugs/human-drug-compounding

Want This Form Automated?

Karpa Health turns static intake forms into a fully automated clinical workflow. Branded, HIPAA-compliant, and connected to compounding pharmacies.

  • Branded intake on your website
  • AI contraindication screening
  • One-click prescribing to pharmacies
  • Automated refill management
  • E-signatures and HIPAA audit trail
  • 50-state provider network included
Book a Demo

Free 30-minute walkthrough

Sources & References

  1. FDA Human Drug Compounding Guidance
  2. FSMB Off-Label Prescribing Guidelines
  3. Endocrine Society Clinical Practice Guidelines

Frequently Asked Questions

What is Kisspeptin used for in clinical practice?

Kisspeptin is used off-label to support the HPG axis in patients with reduced libido, hypogonadotropic hypogonadism, fertility concerns, and hormonal dysregulation. It is being studied as a fertility trigger in assisted reproduction as well.

Can Kisspeptin be used alongside TRT or HRT?

In some protocols, Kisspeptin is used with or in place of traditional hormone therapies. Provider coordination is important to avoid over-stimulation of the HPG axis when combining with exogenous hormones.